Protein Language Models Market Report 2026

The protein language models market size has grown exponentially in recent years. It will grow from $0.97 billion in 2025 to $1.22 billion in 2026 at a compound annual growth rate (CAGR) of 25.5%. The growth in the historic period can be attributed to growth in genomic sequencing data, rising biopharma research spending, expansion of bioinformatics platforms, increase in protein database availability, early adoption of machine learning in biology.

The protein language models market size is expected to see exponential growth in the next few years. It will grow to $3.05 billion in 2030 at a compound annual growth rate (CAGR) of 25.7%. The growth in the forecast period can be attributed to increasing demand for computational protein design, expansion of AI led drug pipelines, rising need for rapid target identification, growing cross industry AI biology collaborations, higher investment in AI life science startups. Major trends in the forecast period include rising use of sequence based protein representation models, expansion of cloud hosted protein modeling platforms, growing demand for protein annotation services, increase in api based bioinformatics toolkits, higher adoption of AI driven drug discovery workflows.

The expansion of precision medicine and personalized therapeutics is expected to drive the growth of the protein language models market in the coming years. Precision medicine and personalized therapeutics refer to healthcare approaches that tailor treatments to individual patient characteristics, such as genetic makeup, biomarkers, and disease profiles, to improve treatment effectiveness and reduce adverse outcomes. Growth in precision medicine and personalized therapeutics is driven by increasing regulatory approvals and research focused on targeted therapies that address specific biological pathways rather than one-size-fits-all treatments. Protein language models support precision medicine by enabling detailed analysis of protein sequences and structures, helping researchers identify therapeutic targets, predict drug responses, and design patient-specific biological treatments more efficiently. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based not-for-profit organization, in 2023, the Food and Drug Administration (FDA) approved 16 new personalized therapies for rare disease patients, marking a sharp increase from six approvals in 2022. Therefore, the expansion of precision medicine and personalized therapeutics is propelling the growth of the protein language models market.

The rising adoption of AI-driven drug discovery is expected to drive the growth of the protein language models market in the coming years. AI-driven drug discovery leverages artificial intelligence to accelerate the identification, design, and optimization of drug candidates through advanced analysis of large-scale biological and chemical data. Adoption of AI in drug discovery is increasing due to its ability to accelerate target identification, optimize candidate selection, and improve research efficiency compared to traditional methods. Protein language models support drug discovery by using deep learning architectures to analyze protein sequences, predict structure-function relationships, and identify meaningful patterns that inform target selection and candidate optimization. For example, in January 2025, according to the World Economic Forum, a Switzerland-based non-profit organization, approximately 30 percent of new drugs are discovered using AI technologies. Therefore, the rising adoption of AI-driven drug discovery is propelling the growth of the protein language models market.

Organizations operating in the protein language models market are focusing on developing advanced AI-driven protein language models to improve protein sequence analysis and accelerate drug discovery and biological research. An AI-driven protein language model uses artificial intelligence trained on large-scale protein sequences to predict, interpret, and generate protein structures and functions that accelerate protein engineering, mutation assessment, and the development of new therapeutic solutions. For example, in September 2024, Ginkgo Bioworks Holdings, Inc., a US-based biotechnology company, launched a Protein Large Language Model and Model API built on Google Cloud technology. The solution is trained on Ginkgo’s proprietary protein dataset and hosted on Vertex AI, enabling enterprises and individual researchers to perform advanced protein sequence analysis and improve pattern recognition, thereby accelerating drug development and biological research workflows.

Major companies operating in the protein language models market are Google LLC, Meta Platforms Inc., Pfizer Inc., Novartis AG, AstraZeneca PLC, NVIDIA Corporation, Owkin Inc., Generate Biomedicines Inc., Recursion Pharmaceuticals Inc., BenevolentAI Limited, Exscientia plc, Dyno Therapeutics Inc., Atomwise Inc., ProteinQure Inc., Cradle Bio B.V., Profluent Bio Inc., BioMap (Beijing) Intelligence Technology Co. Ltd., EvolutionaryScale Inc., Isomorphic Labs Limited, Insilico Medicine Inc., AbSci Corporation, Peptone Ltd., and Valence Labs Inc.

Tariffs are impacting the protein language models market by raising the cost of imported high performance computing hardware and specialized processors used for model training. Increased duties on servers, accelerators, and advanced chips are elevating infrastructure expenses for platform providers and research organizations. Cloud and on premises deployment segments that depend on imported compute equipment are the most affected. North america and asia pacific markets with heavy AI hardware imports are seeing cost pressure and delayed capacity expansion. Service providers are adjusting pricing and shifting workloads to optimized environments. At the same time, tariffs are encouraging regional hardware sourcing and local AI infrastructure development. This supports domestic suppliers and strengthens local compute ecosystems.

The protein language models market research report is one of a series of new reports that provides protein language models market statistics, including protein language models industry global market size, regional shares, competitors with a protein language models market share, detailed protein language models market segments, market trends and opportunities, and any further data you may need to thrive in the protein language models industry. This protein language models market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Protein language models are artificial intelligence systems developed to interpret, encode, and forecast protein characteristics by identifying patterns within amino acid sequences. These systems support protein engineering, functional analysis, and the exploration of molecular interactions. They accelerate scientific research and innovation by offering computational understanding of protein dynamics.

The primary components of protein language models include software, hardware, and services. Software refers to platforms that allow organizations to analyze protein sequences, forecast structures, and simulate biological behaviors using advanced machine learning and language modeling approaches. These solutions are deployed through cloud-based and on-premises models based on infrastructure and computational demands. The applications include drug discovery, protein design, disease identification, functional annotation, and other scientific uses. The end users include pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, and others.

The protein language models market consists of revenues earned by entities by providing services such as model training and fine-tuning, protein sequence annotation, structure and function prediction services, AI-driven drug discovery, cloud-based model hosting, bioinformatics consulting services, and custom model development services. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein language models market also includes sales of embedding generation tools, bioinformatics platforms, protein structure prediction tools, model training frameworks, and application programming interface toolkits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.